Postes actifs de David Lyerly
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
TechLab, Inc.
 TechLab, Inc. Medical SpecialtiesHealth Technology TechLab, Inc. develops, manufactures, and distributes rapid non-invasive intestinal diagnostics. It focuses on enteric disease and microbiology of the intestinal tract, and scope of study includes markers of intestinal inflammation, the toxins of Clostridium difficile, amebiasis, and vaccine development. It offers diagnostic tests for colitis, parasitology, intestinal inflammation, and Shiga toxins of enterohemorrhagic E. coli. The company was founded by Tracy Wilkins in 1989 and is headquartered in Blacksburg, VA. | Fondateur | 01/01/1989 | - |
| Directeur Technique/Scientifique/R&D | 01/09/1989 | - | |
| Directeur/Membre du Conseil | 01/01/1989 | - |
Historique de carrière de David Lyerly
Formation de David Lyerly
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| Wake Forest School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
TechLab, Inc.
TechLab, Inc. Medical SpecialtiesHealth Technology TechLab, Inc. develops, manufactures, and distributes rapid non-invasive intestinal diagnostics. It focuses on enteric disease and microbiology of the intestinal tract, and scope of study includes markers of intestinal inflammation, the toxins of Clostridium difficile, amebiasis, and vaccine development. It offers diagnostic tests for colitis, parasitology, intestinal inflammation, and Shiga toxins of enterohemorrhagic E. coli. The company was founded by Tracy Wilkins in 1989 and is headquartered in Blacksburg, VA. | Health Technology |
- Bourse
- Insiders
- David Lyerly
- Expérience
